PML is a dubious disease in the field of the nervous system, with clinical performance being complex and often involving multi-system fatigue. Early identification and normalisation of clinical care are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
The platform can help align national and international experts with teams to provide accurate diagnosis and treatment plans. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many of the diseases of the nervous system that were previously difficult to treat have been significantly improved. Treatment requires close monitoring of therapeutic effects and adverse reactions and timely adjustment according to the changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of PML-related muscular disorders. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.